logo image
search icon
Gastroretentive Drug Delivery Systems Outsourcing Market

Gastroretentive Drug Delivery Systems Outsourcing Market Size, Share & Trends Analysis Report By Dosage Form (Tablets, Liquid, Microspheres, Capsule, Others), By Region, And By Segment Forecasts, 2023-2031.

Report ID : 2154 | Published : 2023-10-17 | Pages: 178 | Format: PDF/EXCEL

Gastroretentive Drug Delivery Systems Outsourcing Market Size is valued at USD 1.26 Bn in 2022 and is predicted to reach USD 2.32 Bn by the year 2031 at a 7.22% CAGR during the forecast period for 2023-2031.

Gastroretentive Drug Delivery Systems Outsourcing Market

Gastroretentive drug delivery systems are designed for extended retention within the stomach, allowing for direct interaction with ulcer sites and thereby increasing drug concentrations specifically at the affected areas. These systems enable sustained drug release and localized dosage delivery in the stomach and small intestine. The rising incidence of disorders related to the stomach and small intestine is anticipated to drive market demand.

Furthermore, the global increase in disease burdens, coupled with the demonstrated effectiveness of gastroretentive drug delivery systems in addressing conditions like peptic ulcers and gastric ulcers, is a significant driver for the market's expansion in the foreseeable future. These systems extend the retention time in the stomach, leading to enhanced drug concentration at the target site of application. Consequently, this improves drug bioavailability and reduces the required dosage, fueling the growth of the global gastroretentive drug delivery systems market.

Additionally, the growing prevalence of H. Pylori infection, responsible for gastritis, gastric cancer, and gastroduodenal ulcer disease, is also likely to contribute to market growth. Challenges related to ensuring that outsourcing partners possess adequate production capacity and scalability to meet escalating demand can be particularly limiting, especially during periods of rapid market growth.

Competitive Landscape

Some Major Key Players In The Gastroretentive Drug Delivery Systems Outsourcing Market:

  • Catalent
  • Lonza
  • Evonik
  • Colorcon
  • Quotient Sciences
  • Aptar Pharma
  • Aenova Group
  • Evotec
  • Vectura Group Ltd.
  • Ashland
  • Calera Corporation
  • Others

Market Segmentation:

The gastroretentive drug delivery systems outsourcing market is segmented on the basis of the dosage form. According to dosage form, the market is segmented as tablets, liquid, microspheres, capsules and others.

The Tablets Segment Witnessed Growth At A Rapid Rate.

The tablets segment is projected to grow rapidly in the global gastroretentive drug delivery systems outsourcing market. The growing emphasis of manufacturers on developing gastroretentive tablets is anticipated to propel the segment's expansion. Gastroretentive tablets are designed to offer controlled and prolonged release of medication, ensuring a consistent and sustained level of drugs in the bloodstream over an extended duration. This controlled release mechanism reduces the need for frequent dosing, enhancing patient convenience. Additionally, gastroretentive tablets can potentially enhance the bioavailability of certain medications, especially those with limited solubility or permeability.

In The Region, The North American Gastroretentive Drug Delivery Systems Outsourcing Market Holds A Significant Revenue Share.

The North American gastroretentive drug delivery systems outsourcing market is expected to record the maximum market share in terms of revenue in the near future. The expansion of this particular regional market can be attributed to the significant patient population it serves. Furthermore, the market is set to grow with the boost provided by increasing government backing for the pharmaceutical sector. In addition, Asia Pacific is estimeted to grow at a rapid rate in the global gastroretentive drug delivery systems outsourcing market. Several Asian nations have established regulations and incentives aimed at fostering pharmaceutical research and development, particularly in the realm of drug delivery technology. These initiatives hold the promise of attracting both domestic and international companies in search of outsourcing collaborations. 

Recent Developments:

  • In August 2022, Catalent revealed its intention to purchase Metrics Contract Services for USD 475 million. This strategic move aims to enhance Catalent's promising capabilities and increase its oral development and manufacturing capacity.

Gastroretentive Drug Delivery Systems Outsourcing Market Report Scope

Report Attribute

Specifications

Market Size Value In 2022

USD 1.26 Bn

Revenue Forecast In 2031

USD 2.32 Bn

Growth Rate CAGR

CAGR of 7.22% from 2023 to 2031

Quantitative Units

Representation of revenue in US$ Bn and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Dosage

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Catalent, Lonza, Evonik, Colorcon, Quotient Sciences, Aptar Pharma, Aenova Group, Evotec, Vectura Group Ltd., Ashland, Calera Corporation

Customization Scope

Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Gastroretentive Drug Delivery Systems Outsourcing Market Snapshot

Chapter 4. Global Gastroretentive Drug Delivery Systems Outsourcing Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. COVID-19 Impact Analysis

Chapter 5. Market Segmentation 1: By Dosage Form Estimates & Trend Analysis

5.1. By Dosage Form & Market Share, 2019-2031

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Dosage Form:

5.2.1. Tablets

5.2.2. Liquid

5.2.3. Microspheres

5.2.4. Capsule

5.2.5. Others

Chapter 6. Gastroretentive Drug Delivery Systems Outsourcing Market Segmentation 2: Regional Estimates & Trend Analysis

6.1. North America

6.1.1. North America Gastroretentive Drug Delivery Systems Outsourcing Market revenue (US$ Million) estimates and forecasts By Dosage Form, 2023-2031

6.1.2. North America Gastroretentive Drug Delivery Systems Outsourcing Market revenue (US$ Million) estimates and forecasts by country, 2023-2031

6.1.2.1. U.S.

6.1.2.2. Canada

6.2. Europe

6.2.1. Europe Gastroretentive Drug Delivery Systems Outsourcing Market revenue (US$ Million) By Dosage Form, 2023-2031

6.2.2. Europe Gastroretentive Drug Delivery Systems Outsourcing Market revenue (US$ Million) By country, 2023-2031

6.2.2.1. Germany

6.2.2.2. Poland

6.2.2.3. France

6.2.2.4. Italy

6.2.2.5. Spain

6.2.2.6. UK

6.2.2.7. Rest of Europe

6.3. Asia Pacific

6.3.1. Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Market revenue (US$ Million) By Dosage Form, 2023-2031

6.3.2. Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Market revenue (US$ Million) By country, 2023-2031

6.3.2.1. China

6.3.2.2. India

6.3.2.3. Japan

6.3.2.4. Australia

6.3.2.5. Rest of Asia Pacific

6.4. Latin America

6.4.1. Latin America Gastroretentive Drug Delivery Systems Outsourcing Market revenue (US$ Million) By Dosage Form, 2023-2031

6.4.2. Latin America Gastroretentive Drug Delivery Systems Outsourcing Market revenue (US$ Million) By country, (US$ Million) 2023-2031

6.4.2.1. Brazil

6.4.2.2. Rest of Latin America

6.5. Middle East & Africa

6.5.1. Middle East & Africa Gastroretentive Drug Delivery Systems Outsourcing Market revenue (US$ Million) By Dosage Form, (US$ Million)

6.5.2. Middle East & Africa Gastroretentive Drug Delivery Systems Outsourcing Market revenue (US$ Million) By country, (US$ Million) 2023-2031

6.5.2.1. South Africa

6.5.2.2. GCC Countries

6.5.2.3. Rest of MEA

Chapter 7. Competitive Landscape

7.1. Major Mergers and Acquisitions/Strategic Alliances

7.2. Company Profiles

7.2.1. Catalent

7.2.2. Lonza

7.2.3. Evonik

7.2.4. Colorcon

7.2.5. Quotient Sciences

7.2.6. Aptar Pharma

7.2.7. Aenova Group

7.2.8. Evotec

7.2.9. Vectura Group Ltd.

7.2.10. Ashland

Segmentation of Gastroretentive Drug Delivery Systems Outsourcing Market-

Gastroretentive Drug Delivery Systems Outsourcing Market By Dosage Form

  • Tablets
  • Liquid
  • Microspheres
  • Capsule
  • Others

Gastroretentive Drug Delivery Systems Outsourcing Market Seg

Gastroretentive Drug Delivery Systems Outsourcing Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Gastroretentive Drug Delivery Systems Outsourcing Market Size?

Gastroretentive Drug Delivery Systems Outsourcing Market is expected to grow at a 7.22% CAGR during the forecast period for 2023-2031.

Lonza, Evonik, Colorcon, Quotient Sciences, Aptar Pharma, Aenova Group, Evotec, Vectura Group Ltd., Ashland, Calera Corporation

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Medical Devices

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach